Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma

Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) has a poor 5-year survival rate of 5%. Biomarkers for the early detection of pancreatic cancer are urgently needed. Transforming growth factor-beta1 (TGF-β1) is elevated in the tissues and plasma of patients with PDAC. However, no studies systemically report p...

Full description

Bibliographic Details
Main Authors: J. Zhao, Y. Liang, Q. Yin, S. Liu, Q. Wang, Y. Tang, C. Cao
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2016-07-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Pancreatic ductal adenocarcinoma
Marker
TGF-β1
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000800705&lng=en&tlng=en

Similar Items

Similar Items